CSF proteome analysis in clinically isolated syndrome (CIS): Candidate markers for conversion to definite multiple sclerosis
Authors:
- H. TumaniHTH. Tumani
- V. LehmensiekVLV. Lehmensiek
- D. RauDRD. Rau
- I. GuttmannIGI. Guttmann
- G. TauscherGTG. Tauscher
- H. MogelHMH. Mogel
- C. PalmCPC. Palm
- V. HirtVHV. Hirt
- S.D. SuessmuthSSS.D. Suessmuth
- I. Sapunova-MeierISI. Sapunova-Meier
- A.C. LudolphALA.C. Ludolph
- J. BrettschneiderJBJ. Brettschneider
- 1 March 2009
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 452 (2) , 214-217
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- CSF proteome analysis in multiple sclerosis patients by two‐dimensional electrophoresisEuropean Journal of Neurology, 2008
- Cerebrospinal fluid proteome profile in multiple sclerosisMultiple Sclerosis Journal, 2007
- Clinically isolated syndromesNeurology, 2007
- Proteome analysis of cerebrospinal fluid in Guillain–Barré syndrome (GBS)Journal of Neuroimmunology, 2007
- Lack of Association between Antimyelin Antibodies and Progression to Multiple SclerosisNew England Journal of Medicine, 2007
- Decreased Levels of Circulating .ALPHA.2-Heremans-Schmid Glycoprotein/Fetuin-A (AHSG) in Patients with Rheumatoid ArthritisInternal Medicine, 2007
- Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”Annals of Neurology, 2005
- Antioxidant role of human haptoglobinProteomics, 2004
- α2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-β/Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and RemodelingJournal of Biological Chemistry, 2002
- Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant.Journal of Clinical Investigation, 1979